Another coactivator of TEAD4 is glucocorticoid receptor which binds TEAD4 and acts, in a YAP-independent manner, to promote transcription in breast cancer (He et al., 2019; Park et al., 2019). This evidence concerns the gene NR3C1 and breast carcinoma.